Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee

• Status: Completed
• Trial end date: 2014-10-21

Summary

• To investigate the safety and tolerability of BI 1026706 in male and female healthy subjects and osteoarthritis (OA) patients following oral administration of repeated rising doses

• To explore the pharmacokinetics after multiple rising doses of BI 1026706 in male and female healthy subjects and OA patients

• The assessment of pharmacodynamics in OA patients

• Phase: Phase 1

Details

• Lead Sponsor: Boehringer Ingelheim